Bluepharma Pharmaceutical Industry, S.A.

Poland

All drugs from this manufacturer

  • ABIRATERONE PHARMASCIENCE

    The medicine is intended for adult men with prostate cancer that has metastasized to other parts of the body. It works by inhibiting the production of testosterone, which can slow the growth of the tumor.

    Dosage form: tablets, film-coated

    Active substance Dosage
    abiraterone acetate 500 mg

    ATC: L02BX03

  • The medicine is used to treat gout by reducing the concentration of uric acid in the body. At a dose of 120 mg, it is also used to prevent high uric acid levels in patients starting chemotherapy for blood cancer.

    Dosage form: tablets, film-coated

    Active substance Dosage
    febuxostat 80 mg

    ATC: M04AA03

  • The medicine is used in adults for the treatment of gout (by reducing uric acid levels) and to prevent high uric acid levels in the blood during chemotherapy for blood cancer.

    Dosage form: tablets, film-coated

    Active substance Dosage
    febuxostat 120 mg

    ATC: M04AA03

  • This medicine is used in adults and children and adolescents (over 10 years of age) for the treatment of relapsing-remitting multiple sclerosis (MS), especially in people for whom other treatments have not worked or in whom the disease is progressing rapidly and severely.

    Dosage form: capsules, hard

    Active substance Dosage
    fingolimod 0.5 mg

    ATC: L04AA27

  • The medicine is used in adults to treat bacterial infections, such as sinusitis, acute exacerbation of chronic bronchitis, pneumonia (community-acquired), and certain upper respiratory tract infections. It may also be used to complete treatment for lung or skin and soft tissue infections if an infusion was previously administered.

    Dosage form: tablets, film-coated

    Active substance Dosage
    moxifloxacin 400 mg

    ATC: J01MA14

  • It is used for the treatment of acute pain and menstrual pain.

    Dosage form: tablets

    Active substance Dosage
    nimesulide 100 mg

    ATC: M01AX17

  • The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and progressive pancreatic neuroendocrine tumors (pNET) that cannot be surgically removed.

    Dosage form: capsules, hard

    Active substance Dosage
    sunitinib hydrochloride 13.646 mg

    ATC: L01XE04

  • The medicinal product is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and progressive, unresectable pancreatic neuroendocrine tumors (pNET).

    Dosage form: capsules, hard

    Active substance Dosage
    sunitinib hydrochloride 27.293 mg

    ATC: L01XE04

  • The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET) that are in the progressive phase and cannot be surgically removed.

    Dosage form: capsules, hard

    Active substance Dosage
    sunitinib hydrochloride 40.939 mg

    ATC: L01XE04

  • The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and progressive pancreatic neuroendocrine tumors (pNET) that cannot be surgically removed.

    Dosage form: capsules, hard

    Active substance Dosage
    sunitinib hydrochloride 54.585 mg

    ATC: L01XE04